The Blue Cross Blue Shield Association, along with its 28 member health plans, have reportedly racked up at least 27 antitrust lawsuits against the entities. The lawsuits claim a conspiracy among the BCBS conglomerate to break-up the US healthcare market geographically to avoid competing with each other. Reports say the plaintiffs argue the licensing agreements that the insurer has with member plans is anticompetitive and a violation of the Sherman Act, among other antitrust laws; they are seeking to prevent the competition restriction in certain states, as well as three times their actual damages. BCBS held a legal status conference last Thursday concerning the cases.
Featured News
Compass Faces New Federal Antitrust Fight Over Private Home Listings
Oct 22, 2026 by
CPI
Deutsche Boerse’s $6 Billion Allfunds Deal Faces EU Decision by Nov. 27
Oct 22, 2026 by
CPI
German Court Orders MAN, Daimler Truck to Compensate Customers in Price-Fixing Case
Oct 22, 2026 by
CPI
FTC Brings Antitrust Enforcement to Dallas
Oct 22, 2026 by
CPI
Publishers Urge EU, UK Regulators to Block Meta’s New Terms
Oct 22, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – EU Merger Guidelines
Oct 19, 2026 by
CPI
In Praise of Theories of Benefits
Oct 19, 2026 by
Cyril Hariton & Pierre Regibeau
Closing the Efficiencies Gap
Oct 19, 2026 by
Kasia Czapracka & Marika Harjula
Analysis of Dynamic Trade-Offs Under the New Guidelines: Would Cases Like Amazon/Irobot Turn Out Differently?
Oct 19, 2026 by
Oliver Latham, Sam Marden, Saul Mendelsohn & Serge Moresi
Exploitative Portfolio Effects In EU Merger Control: From Mars/Kellanova to the Draft Merger Guidelines
Oct 19, 2026 by
Niels Baeten, Danette Chan & Elizabeth Malik